Approval would bolster US vaccine drive and help ease parents’ worries over kids’ exposure to virus
The US Food and Drug Administration is preparing to authorize the Pfizer/BioNTech Covid vaccine for adolescents aged between 12 and 15 years by early next week, the New York Times reported on Monday, citing federal officials familiar with the agency’s plans.
An approval is highly anticipated after the drugmakers said in March that the vaccine had been found to be safe, effective and produced robust antibody responses in 12- to 15-year-olds in a clinical trial.
Continue reading...Know the benifits of facebook marketing ---http://bit.ly/2RgChw3
0 Comments